🧪 Hypotheses

therapeutic 1.00

Metabolic Reprogramming to Reverse Senescence

🧬 SIRT1,PGC1A,NAMPT 🏥 N/A

✅ 0.90 ✨ 0.60 💥 0.00

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...

therapeutic 1.00

Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and block tau propagation in AD

🧬 SST 🏥 Alzheimer's disease

✅ 0.87 ✨ 0.79 💥 0.81

## Molecular Mechanism and Rationale...

therapeutic 0.99

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant-path gamma gating in AD

🧬 SST 🏥 Alzheimer's disease

✅ 0.86 ✨ 0.78 💥 0.82

## Molecular Mechanism and Rationale...

therapeutic 0.96

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization

🧬 BDNF 🏥 Alzheimer's disease

✅ 0.70 ✨ 0.82 💥 0.83

## Molecular Mechanism and Rationale...

therapeutic 0.96

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation via perforant path i

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.87 ✨ 0.78 💥 0.81

## Molecular Mechanism and Rationale...

therapeutic 0.96

SASP Modulation Rather Than Cell Elimination

🧬 NFKB1,IL1B,BDNF 🏥 N/A

✅ 0.80 ✨ 0.70 💥 0.00

# SASP Modulation Rather Than Cell Elimination...

therapeutic 0.95

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance

🧬 SST 🏥 Alzheimer's disease

✅ 0.85 ✨ 0.82 💥 0.82

## Molecular Mechanism and Rationale...

therapeutic 0.95

LRP1-Dependent Tau Uptake Disruption

🧬 LRP1 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

# LRP1-Dependent Tau Uptake Disruption in Tauopathic Neurodegeneration...

therapeutic 0.94

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.86 ✨ 0.79 💥 0.80

## Molecular Mechanism and Rationale...

therapeutic 0.94

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 Alzheimer's disease

✅ 0.00 ✨ 0.00 💥 0.00

# Dual-Receptor Antibody Shuttling: A Strategic Approach to Overcoming Blood-Brain Barrier Limitations in Neurodegenerative Disease Therapy...

therapeutic 0.90

Closed-loop transcranial alternating current stimulation to restore hippocampal-prefrontal gamma synchrony via PV intern

🧬 SST 🏥 Alzheimer's disease

✅ 0.88 ✨ 0.78 💥 0.81

## Molecular Mechanism and Rationale...

therapeutic 0.90

Autophagy-Senescence Axis Therapeutic Window

🧬 ATG7,BCL2,BCL2L1 🏥 N/A

✅ 0.60 ✨ 0.80 💥 0.00

# Autophagy-Senescence Axis Therapeutic Window: Sequential Targeting of ATG7 and BCL-2 Family Proteins in Neurodegeneration...

therapeutic 0.89

Palmitoylethanolamide-Based Endocannabinoid Therapy

🧬 PPARA 🏥 N/A

✅ 0.00 ✨ 0.00 💥 0.00

**Background and Rationale**...

therapeutic 0.89

Closed-loop focused ultrasound targeting CA1 PV interneurons to restore theta-gamma coupling and block synaptotoxic Aβ o

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.65 ✨ 0.88 💥 0.78

## Molecular Mechanism and Rationale...

therapeutic 0.89

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore ento

🧬 SST 🏥 Alzheimer's disease

✅ 0.45 ✨ 0.90 💥 0.80

## Molecular Mechanism and Rationale...

therapeutic 0.85

CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal

🧬 CYP46A1 🏥 neurodegeneration

✅ 0.60 ✨ 0.75 💥 0.80

## Molecular Mechanism and Rationale...

therapeutic 0.85

Selective Neutral Sphingomyelinase-2 Inhibition Therapy

🧬 SMPD3 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

This hypothesis proposes selective pharmacological inhibition of neutral sphingomyelinase-2 (nSMase2, encoded by SMPD3) to prevent pathological cerami...

therapeutic 0.84

Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau propagation in AD

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.65 ✨ 0.78 💥 0.75

## Molecular Mechanism and Rationale...

therapeutic 0.84

Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.45 ✨ 0.78 💥 0.68

## Molecular Mechanism and Rationale...

therapeutic 0.84

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and prevent tau seeding i

🧬 PVALB 🏥 Alzheimer's disease

✅ 0.45 ✨ 0.85 💥 0.75

## Molecular Mechanism and Rationale...

therapeutic 0.83

Senescent Cell ASM-Complement Cascade Intervention

🧬 SMPD1 🏥 neurodegeneration

✅ 0.68 ✨ 0.78 💥 0.75

## Molecular Mechanism and Rationale...

therapeutic 0.82

Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activation targeting dendritic i

🧬 SST 🏥 Alzheimer's disease

✅ 0.45 ✨ 0.80 💥 0.70

## Molecular Mechanism and Rationale...

therapeutic 0.82

Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration

🧬 SMPD3 🏥 neurodegeneration

✅ 0.68 ✨ 0.78 💥 0.75

## Molecular Mechanism and Rationale...

therapeutic 0.81

Extracellular Vesicle Biogenesis Modulation

🧬 CHMP4B 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

**Background and Rationale**...

therapeutic 0.81

Selective Acid Sphingomyelinase Modulation Therapy

🧬 SMPD1 🏥 neurodegeneration

✅ 0.90 ✨ 0.70 💥 0.85

**Overview**...

therapeutic 0.80

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal-prefronta

🧬 SST 🏥 Alzheimer's disease

✅ 0.35 ✨ 0.82 💥 0.78

## Molecular Mechanism and Rationale...

therapeutic 0.80

CYP46A1 Overexpression Gene Therapy

🧬 CYP46A1 🏥 neurodegeneration

✅ 0.60 ✨ 0.95 💥 0.90

**CYP46A1 Overexpression Gene Therapy for Alzheimer's Disease**...

therapeutic 0.80

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

🧬 TREM2 🏥 neurodegeneration

✅ 0.82 ✨ 0.65 💥 0.75

Background and Rationale...

therapeutic 0.79

APOE-Dependent Autophagy Restoration

🧬 MTOR 🏥 neurodegeneration

✅ 0.90 ✨ 0.60 💥 0.80

APOE-Dependent Autophagy Restoration proposes targeting the mechanistic link between apolipoprotein E4 (APOE4) genotype and impaired macroautophagy as...

therapeutic 0.78

Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation

🧬 HCAR2 🏥 neurodegeneration

✅ 0.82 ✨ 0.70 💥 0.75

Beyond serving as metabolic fuel, β-hydroxybutyrate (BHB) signals through hydroxycarboxylic acid receptor 2 (HCAR2/GPR109A) on astrocytes to suppress ...